Cargando…
A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues
Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therapy for newborn sepsis. We hypothesized that adminis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538609/ https://www.ncbi.nlm.nih.gov/pubmed/33072121 http://dx.doi.org/10.3389/fimmu.2020.577878 |
_version_ | 1783590900685864960 |
---|---|
author | Speer, Esther M. Diago-Navarro, Elizabet Ozog, Lukasz S. Raheel, Mahnoor Levy, Ofer Fries, Bettina C. |
author_facet | Speer, Esther M. Diago-Navarro, Elizabet Ozog, Lukasz S. Raheel, Mahnoor Levy, Ofer Fries, Bettina C. |
author_sort | Speer, Esther M. |
collection | PubMed |
description | Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therapy for newborn sepsis. We hypothesized that administration of PTX in addition to antibiotics decreases live bacteria-induced pro-inflammatory and/or enhances anti-inflammatory cytokine production in septic neonatal mice without augmenting bacterial growth. Methods: Newborn C57BL/6J mice (< 24 h old) were injected intravenously with 10(5) colony forming units (CFUs)/g weight of a bioluminescent derivative of the encapsulated clinical isolate Escherichia coli O18:K1. Adequacy of intravenous injections was validated using in vivo bioluminescence imaging and Evans blue. Pups were treated with gentamicin (GENT), PTX, (GENT + PTX) or saline at 0, 1.5, or 4 h after sepsis initiation, and euthanized after an additional 4 h. CFUs and cytokines were measured from blood and homogenized organ tissues. Results: GENT alone inhibited bacterial growth, IL-1β, and IL-6 production in blood and organs. Addition of PTX to GENT profoundly inhibited E. coli-induced TNF and enhanced IL-10 in blood of newborn mice at all timepoints, whereas it primarily upregulated IL-10 production in peripheral organs (lung, spleen, brain). PTX, whether alone or adjunctive to GENT, did not increase microbial colony counts in blood and organs. Conclusion: Addition of PTX to antibiotics in murine neonatal E. coli sepsis promoted an anti-inflammatory milieu through inhibition of plasma TNF and enhancement of IL-10 production in plasma and organs without increasing bacterial growth, supporting its utility as a potential adjunctive agent for newborn sepsis. |
format | Online Article Text |
id | pubmed-7538609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75386092020-10-17 A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues Speer, Esther M. Diago-Navarro, Elizabet Ozog, Lukasz S. Raheel, Mahnoor Levy, Ofer Fries, Bettina C. Front Immunol Immunology Introduction: Neonatal sepsis triggers an inflammatory response that contributes to mortality and multiple organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses pro-inflammatory cytokines, is a candidate adjunctive therapy for newborn sepsis. We hypothesized that administration of PTX in addition to antibiotics decreases live bacteria-induced pro-inflammatory and/or enhances anti-inflammatory cytokine production in septic neonatal mice without augmenting bacterial growth. Methods: Newborn C57BL/6J mice (< 24 h old) were injected intravenously with 10(5) colony forming units (CFUs)/g weight of a bioluminescent derivative of the encapsulated clinical isolate Escherichia coli O18:K1. Adequacy of intravenous injections was validated using in vivo bioluminescence imaging and Evans blue. Pups were treated with gentamicin (GENT), PTX, (GENT + PTX) or saline at 0, 1.5, or 4 h after sepsis initiation, and euthanized after an additional 4 h. CFUs and cytokines were measured from blood and homogenized organ tissues. Results: GENT alone inhibited bacterial growth, IL-1β, and IL-6 production in blood and organs. Addition of PTX to GENT profoundly inhibited E. coli-induced TNF and enhanced IL-10 in blood of newborn mice at all timepoints, whereas it primarily upregulated IL-10 production in peripheral organs (lung, spleen, brain). PTX, whether alone or adjunctive to GENT, did not increase microbial colony counts in blood and organs. Conclusion: Addition of PTX to antibiotics in murine neonatal E. coli sepsis promoted an anti-inflammatory milieu through inhibition of plasma TNF and enhancement of IL-10 production in plasma and organs without increasing bacterial growth, supporting its utility as a potential adjunctive agent for newborn sepsis. Frontiers Media S.A. 2020-09-23 /pmc/articles/PMC7538609/ /pubmed/33072121 http://dx.doi.org/10.3389/fimmu.2020.577878 Text en Copyright © 2020 Speer, Diago-Navarro, Ozog, Raheel, Levy and Fries. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Speer, Esther M. Diago-Navarro, Elizabet Ozog, Lukasz S. Raheel, Mahnoor Levy, Ofer Fries, Bettina C. A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title | A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title_full | A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title_fullStr | A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title_full_unstemmed | A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title_short | A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues |
title_sort | neonatal murine escherichia coli sepsis model demonstrates that adjunctive pentoxifylline enhances the ratio of anti- vs. pro-inflammatory cytokines in blood and organ tissues |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538609/ https://www.ncbi.nlm.nih.gov/pubmed/33072121 http://dx.doi.org/10.3389/fimmu.2020.577878 |
work_keys_str_mv | AT speerestherm aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT diagonavarroelizabet aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT ozoglukaszs aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT raheelmahnoor aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT levyofer aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT friesbettinac aneonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT speerestherm neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT diagonavarroelizabet neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT ozoglukaszs neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT raheelmahnoor neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT levyofer neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues AT friesbettinac neonatalmurineescherichiacolisepsismodeldemonstratesthatadjunctivepentoxifyllineenhancestheratioofantivsproinflammatorycytokinesinbloodandorgantissues |